|
ARL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.347800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.160760E-01 |
| Normal-vs-Stage2 |
8.994400E-01 |
| Normal-vs-Stage3 |
1.113550E-01 |
| Normal-vs-Stage4 |
2.141000E-01 |
| Stage1-vs-Stage2 |
4.020000E-01 |
| Stage1-vs-Stage3 |
4.732400E-01 |
| Stage1-vs-Stage4 |
9.131000E-01 |
| Stage2-vs-Stage3 |
2.549200E-01 |
| Stage2-vs-Stage4 |
4.077400E-01 |
| Stage3-vs-Stage4 |
5.819600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.761030E-01 |
| Normal-vs-AfricanAmerican |
5.77720000000115E-05 |
| Normal-vs-Asian |
3.884000E-02 |
| Caucasian-vs-AfricanAmerican |
9.954000E-04 |
| Caucasian-vs-Asian |
1.070590E-01 |
| AfricanAmerican-vs-Asian |
9.644800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.413800E-02 |
| Normal-vs-Female |
6.162200E-01 |
| Male-vs-Female |
9.443800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.718800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.372390E-01 |
| Normal-vs-Age(61-80Yrs) |
2.385000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.708600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.166000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.802200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.818220E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.118000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.101600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.955000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.766200E-01 |
| Normal-vs-Grade 2 |
8.391800E-01 |
| Normal-vs-Grade 3 |
4.041800E-02 |
| Normal-vs-Grade 4 |
6.229500E-04 |
| Grade 1-vs-Grade 2 |
7.082000E-01 |
| Grade 1-vs-Grade 3 |
6.987200E-01 |
| Grade 1-vs-Grade 4 |
1.847800E-01 |
| Grade 2-vs-Grade 3 |
1.127150E-01 |
| Grade 2-vs-Grade 4 |
2.702400E-03 |
| Grade 3-vs-Grade 4 |
5.338000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.839600E-01 |
| Normal-vs-ccB subtype |
3.375800E-02 |
| ccA subtype-vs-ccB subtype |
4.978600E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.610200E-01 |
| Normal-vs-N1 |
5.453400E-01 |
| N0-vs-N1 |
7.717000E-01 |
|
|
